1 sing date of birth, diagnosis, or last known
vital status.
2 AIDS Programme database to ascertain ART and
vital status.
3 elated to trial phase, institution type, and
vital status.
4 psychotic depression but was not related to
vital status.
5 ructosamine assays were performed blinded to
vital status.
6 ology Score II), organ failure supports, and
vital status.
7 ex to determine clinical characteristics and
vital status.
8 contacted for symptoms, clinical events, and
vital status.
9 Of 497 (86%) with ascertained
vital status,
340 (69%) were alive and, in 278 (82%) cas
10 nd sex among guideline-eligible patients for
vital status (
alive/dead) at 24 months.
11 follow-up of 212733 surgical cases using VHA
Vital Status and admission records were obtained with 10
12 roughout the United States and combined with
vital status and cause of death data through December 31
13 Vital status and cause of death of all patients eligible
14 Vital status and cause of death was determined during 19
15 Their
vital status and cause of death were ascertained by comp
16 Vital status and cause of death were ascertained for the
17 Vital status and cause of death were ascertained through
18 Vital status and cause of death were ascertained through
19 Vital status and cause of death were determined through
20 cluding initial SUD episode and any relapse,
vital status and cause of death, and professional conseq
21 an areas followed from 1982 through 2004 for
vital status and cause of death.
22 Vital status and date and cause of death were ascertaine
23 e and passive follow-up methods to determine
vital status and date of death for 1,954 pancreatic canc
24 Vital status and death date information was queried usin
25 We ascertained the
vital status and development of ESRD in 143 living kidne
26 ery were contacted by telephone to determine
vital status and functional capacity using the Duke Acti
27 ted symptom burden, ventilator outcomes, and
vital status and functional status at discharge and 3 an
28 Vital status and history of MI during follow-up were det
29 ons (2011-2013) with active surveillance for
vital status and hospitalizations.
30 We ascertained the
vital status and lifetime risk of ESRD in 3698 kidney do
31 Vital status and medical history were ascertained from a
32 Vital status and MRS at the end of the trial were known
33 on surveys in these towns to collect data on
vital status and other characteristics of survey respond
34 rhans'-cell histiocytosis to ascertain their
vital status and whether cancer had been diagnosed.
35 s calculated on the basis of length of stay,
vital status,
and 30-day readmissions.
36 Cancer recurrence,
vital status,
and cause of death were documented for a m
37 Cancer recurrence,
vital status,
and cause of death were documented for a m
38 s and emergency department visits, patients'
vital status,
and current antipsychotic drug status was
39 logy Project through December 1994 to obtain
vital status,
and death certificates were obtained for t
40 frequency matched to cases on year of birth,
vital status,
and maternal county of residence at delive
41 We determined treatments,
vital status,
and other factors using registry, intervie
42 all subjects to whom SSA assigned an unknown
vital status as well as all subjects whom SSA identified
43 Recently, during the
vital status ascertainment phase of an ongoing occupatio
44 protocol will enable researchers to maximize
vital status ascertainment while containing costs associ
45 mented by CLU vital status updates, improves
vital status assessment while increasing substantially t
46 Vital status at 1 year was available in 936 of 944 (99.2
47 days was sent a return postcard to ascertain
vital status at 1 year.
48 ospital charges for the index admission, and
vital status at 100 days.
49 Vital status at 24 months was known for 2960 (88.5%) pat
50 Vital status at 3 months was determined, and independent
51 ssion status based on clinical interview and
vital status at 5 years by using the National Death Inde
52 Loss to follow-up was low with
vital status at 6 months of age reported for 22,698 (98.
53 criterion standards of current work status;
vital status at 6 years; grip strength; walking velocity
54 f mechanical ventilation, and information on
vital status at hospital discharge was acquired.
55 Vital status at hospital discharge was the outcome measu
56 ristics were recorded as were procedures and
vital status at hospital discharge.
57 existing studies have not considered patient
vital status at ICU discharge.
58 Vital status at June 30, 1992, was obtained for the 1134
59 people without MS by sex, year of birth, age/
vital status at MS diagnosis, and region of residence (c
60 The outcome was
vital status at PICU discharge.
61 Based on patients' diagnostic codes and
vital status at the end of the admission, disease focus
62 time of SCU admission, at 24 hrs, as well as
vital status at the time of discharge from the SCU and h
63 Vital status,
cause of death and coronary heart disease
64 it was made about 60 days later to ascertain
vital status,
clinical outcome, and interval growth.
65 tion, 66 [11] years); long-term follow-up of
vital status,
conducted annually until 2005, ranged from
66 The
vital status could be updated on Dec 31, 2008, in all re
67 The process uses the
vital status data service of the Social Security Adminis
68 VA and Medicare
vital-status data were used to calculate one-year surviv
69 21,390 HCC cases diagnosed with follow-up of
vital status during 1998-2008, there were 4,727 (22%) wi
70 ertained through corresponding inpatient and
vital status files, and risk-standardized rates were cal
71 rates were ascertained through corresponding
vital status files.
72 y and 1-year mortality were calculated using
Vital Status Files.
73 Vital status follow-up began with the date of exit from
74 Vital status for 1,043 (97%) participants was ascertaine
75 We determined
vital status for 561 miners, and obtained a follow-up qu
76 The NDI and active follow-up agreed on
vital status for 91.2% of Hispanic EPESE subjects.
77 sive hemodynamic data, echocardiography, and
vital status for all patients referred for right heart c
78 invasive hemodynamics, echocardiography, and
vital status for all patients.
79 e National Death Index was used to ascertain
vital status for patients who could not be contacted.
80 edicaid Services claims data, we ascertained
vital status from date of surgery through December 31, 2
81 rom the National Danish Patient Registry and
vital status from the National Danish Civil Registration
82 gh only 34% of these differentiated LTFU for
vital status from withdrawal of consent.
83 Patient
vital status generally is passively obtained by cancer r
84 Vital status has been traced, and risk factors in adulth
85 Data collected included
vital status,
histologic findings, and therapeutic inter
86 We report ART initiation and
vital status in children with HIV after 7 years of rollo
87 Vital status in September 2010 was obtained from the Med
88 Complete information about
vital status in the Ontario Cancer Registry was availabl
89 Vital status information was available for all patients
90 Vital status information was queried using an institutio
91 n 1964 and 2013; 176 had valid follow-up and
vital status information.
92 3 and 12 months post-discharge, we assessed
vital status,
instrumental activities of daily living, b
93 in 1999 to 2000, which included determining
vital status,
interviewing participants or proxies, and
94 Complete and accurate ascertainment of
vital status is of great importance in cohort studies.
95 For stage I, data on all subjects for whom
vital status is unconfirmed should be sent to the SSA.
96 Depression status, cause of death, and
vital status might have been misclassified.
97 Two-year
vital status (
minimum, 688 days) was determined in 2375
98 e electronic health records were linked with
vital status obtained from the National Death Index.
99 data were merged with BIRLS to determine the
vital status of 105,951 patients who underwent 8 types o
100 The
vital status of 12,373 people aged 65 y and over was det
101 The
vital status of 265 SLE patients and 355 controls enroll
102 analytic techniques were used to compare the
vital status of 61 patients with psychotic major depress
103 compared clinical presentation, relapse, and
vital status of 78 patients with type 1 AIP who met the
104 The
vital status of each member of this cohort was ascertain
105 The
vital status of each patient was determined as of Decemb
106 h Index to obtain updated information on the
vital status of participants and to determine causes of
107 We determined the
vital status of patients over a median of 3.6 years (10%
108 The
vital status of study participants was ascertained throu
109 Vital status of study participants was ascertained throu
110 Vital status of the patients was determined through the
111 The
vital status of the subjects was identified in October 1
112 Nine to 12 years later, the
vital status of these subjects was determined.
113 system (BIRLS) is a VA file that depicts the
vital status of U.S. veterans with 87% to 95% accuracy.
114 We recorded
vital status on June 1, 1999, and ascertained causes of
115 Patients with unknown or uninterpretable
vital status or graft survival time (n=264 [0.8%]) were
116 We incorporated the
vital status outcomes for these patients into analyses o
117 Vital status,
risk factor, and cause-of-death data, coll
118 n a cohort of over 200,000 employees, an SSA
vital status search reduced the size of the NDI death re
119 which respondents provided information about
vital status,
sociodemographic and socioeconomic charact
120 Patients were followed for
vital status through 180 days.
121 urvey in 1976 to 1980 and were monitored for
vital status through 1992 in the Second National Health
122 Participants were followed for
vital status through 1998.
123 Vital status through 2003 was obtained from the US Natio
124 5-2003, were followed for their CRC-specific
vital status through 2005 and overall vital status throu
125 ecific vital status through 2005 and overall
vital status through 2006.
126 luated in 1992 to 1996 and were followed for
vital status through 2010.
127 They compared
vital status through 7 years ascertained from an NDI sea
128 iagnosed between 1988-2009 in California for
vital status through December 31, 2010.
129 quartile range, 43-89 months) (follow-up for
vital status through December 31, 2011), 2119 patients (
130 988 and 2005 in California were observed for
vital status through November 2007.
131 ual characteristics in 1982 and follow-up of
vital status through to 2000.
132 Death Index was used to ascertain patients'
vital statuses through 2007.
133 Death Index was used to ascertain patients'
vital statuses through December 31, 2007.
134 s, the authors recommend a revised two-stage
vital status tracing protocol.
135 0 (n = 1,137,311) and tracked each subject's
vital status until December 31, 2009.
136 criteria) was assembled and followed up for
vital status until July 1, 2008.
137 Vital status up to 1 year after discharge was obtained f
138 in cryopreserved serum samples and reviewed
vital status up to Jan 1, 2011, through contact with nex
139 match criteria, further supplemented by CLU
vital status updates, improves vital status assessment w
140 Vital status was ascertained 12-16 y later.
141 Vital status was ascertained by telephone and by queryin
142 Long-term
vital status was ascertained by using the respective Nat
143 Vital status was ascertained for 1429 (99.2%) participan
144 between June 10, 2011, and Aug 27, 2012, and
vital status was ascertained for 860 (87%).
145 Vital status was ascertained in a random sample of 208 p
146 Vital status was ascertained on 96.9% of the OOA cohort
147 Vital status was ascertained through 1992.
148 The
vital status was ascertained through computerized linkag
149 ecember 2010 (median follow-up of 20 years),
vital status was ascertained with a National Death Index
150 lost patients were sought, and in 175 (85%)
vital status was ascertained.
151 In addition, the
vital status was assessed at 24 months.
152 Vital status was assessed over 2 years, and outcomes wer
153 Vital status was assessed through 180 days.
154 Follow-up
vital status was assessed, with the primary endpoint of
155 Vital status was available for 11 621 patients.
156 Vital status was available for 97.2% of patients at 3 ye
157 Vital status was available in more than 95% of participa
158 variables were measured, and information on
vital status was collected from demographic files at fol
159 eexamination (1990-1993), and information on
vital status was collected over the subsequent 5 years.
160 Vital status was collected.
161 as completed in June 2000, and follow-up for
vital status was completed in September 2007.
162 Vital status was confirmed for >99% of 1,954 patients.
163 Vital status was determined by linkage to the National D
164 Vital status was determined by ongoing contact and a Nat
165 Vital status was determined from hospital records and th
166 Vital status was determined in 1972.
167 Vital status was determined in 361 participants (97.8%)
168 Vital status was determined using the Social Security De
169 Vital status was established for all but 3 of 1351 patie
170 Vital status was followed for 9 years.
171 Vital status was followed from 1942 to 2003, and cause-s
172 Vital status was followed through December 30, 2003 (med
173 the United States Renal Data System's data;
vital status was from the National Death Index.
174 Vital status was known for all men on the 25th anniversa
175 At trial completion,
vital status was not known for 143 (1%) patients who wer
176 Vital status was obtained by linkage to the National Dea
177 Vital status was obtained from record linkages with the
178 Vital status was obtained from the Social Security Death
179 By National Death Index,
vital status was obtained in 99.7% (n = 8221) with a mea
180 Infant
vital status was recorded for 28 completed days.
181 After follow-up, the
vital status was recorded in all patients.
182 Vital status was verified in each patient.
183 he national population register to determine
vital status were combined with data from Europe and Nor
184 Patients'
vital statuses were tracked using the National Death Ind
185 Vital status within 24 h of the echocardiographic study